Represented Annovis Bio on Exchange Act Reporting, Shelf and Securities Offerings

Represented Annovis Bio, Inc. on its ongoing Exchange Act reporting requirements, the preparation of a Universal Shelf and numerous securities offerings including registered direct offerings, confidentially marketed public offering and an ATM offering.